RSS   Newsletter   Contact   Advertise with us
Post Online Media

F2G appoints Ralf Schmid as CFO

F2GF2G Ltd, a biotech company, announced the appointment of Ralf Schmid to the position of chief financial officer.
Article continues below

READ MORE HERE appoints Ralf Herrtwich to lead automotive business

Mr. Schmid brings over 20 years’ experience to F2G, with considerable expertise in M&A, licensing, public and private market transactions.

Mr. Schmid joins F2G from Nabriva Theraputics AG, where he served on the management board since the company’s inception in 2006. In his role as Chief Financial and Chief Operating Officer, he was instrumental in taking the company public on NASDAQ in September 2015.

Mr. Schmid has held various senior positions in finance and administration at several multi-national companies including Sandoz where he led the spin-off of Nabriva.

He holds a Master’s degree in finance and economics from Otto-Friedrich-Universität Bamberg, Germany.

 LATEST MOVES FROM United Kingdom 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy